ProductsPricingResearchSupportPartner
​

Login
Open Account
Home > Stocks > ZIMLAB
Pharmaceuticals
Small Cap

Zim Laboratories Share Price

NSE
ZIMLAB •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Zim Laboratories Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Login
Open Account
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
25.64% Gain from 52W Low
11
TTM PE Ratio
Below industry Median
30.7
Price to Book Ratio
Below industry Median
2.3
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-3.8

Zim Laboratories Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Revenue
QuarterlyYearly
Jun 2024 - 81.8244 Cr Mar 2024 - 372.6083 Cr
Mar 2024 - 117.8628 Cr Mar 2023 - 404.9403 Cr
Dec 2023 - 96.2926 Cr Mar 2022 - 337.8295 Cr
Sep 2023 - 85.8261 Cr Mar 2021 - 309.6002 Cr
Jun 2023 - 67.4429 Cr Mar 2020 - 282.26 Cr
Net Profit/Loss
QuarterlyYearly
Jun 2024 - 0.8983 Cr Mar 2024 - 17.2463 Cr
Mar 2024 - 8.0856 Cr Mar 2023 - 24.4345 Cr
Dec 2023 - 4.7846 Cr Mar 2022 - 14.5504 Cr
Sep 2023 - 4.1495 Cr Mar 2021 - 7.3175 Cr
Jun 2023 - 0.2266 Cr Mar 2020 - 3.2966 Cr

Zim Laboratories Ltd shareholding Pattern

Promoter
33.3%
Domestic Institutions
0.1%
Public
66.6%
Promoter
33.3%
Public
66.7%
Promoter
33.3%
Public
66.7%
Promoter
33.3%
Public
66.8%
Promoter
33.3%
Foreign Institutions
0.1%
Public
66.7%
Promoter
33.3%
Public
66.7%

Zim Laboratories Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
10
5Day EMA
114.50
10Day EMA
115.50
12Day EMA
115.60
20Day EMA
115.40
26Day EMA
115.00
50Day EMA
113.30
100Day EMA
111.50
200Day EMA
110.10
5Day SMA
114.60
10Day SMA
116.70
20Day SMA
116.30
30Day SMA
114.30
50Day SMA
112.80
100Day SMA
111.20
150Day SMA
108.60
200Day SMA
109.60
Delivery & Volume
Delivery Volume %

Day

57.60%

Week

56.10%

Month

61.40%

Day
Combined Delivery Volume- 63694 Rs
NSE+BSE Traded Volume- 110632 Rs

Week
Combined Delivery Volume- 106908 Rs
NSE+BSE Traded Volume- 190529 Rs

Month
Combined Delivery Volume- 281207 Rs
NSE+BSE Traded Volume- 458139 Rs

Resistance & Support
113.02
Pivot
Resistance
First Resistance
113.88
Second Resistance
114.82
Third Resistance
115.68
Support
First Support
112.08
Second support
111.22
Third Support
110.28
Relative Strength Index
45.97
Money Flow Index
87.17
MACD
0.63
MACD Signal
1.39
Average True Range
5.02
Average Directional Index
25.75
Rate of Change (21)
2.87
Rate of Change (125)
12.28
Lyka Labs Ltd.
₹ 152.90
Vikram Thermo (India) Ltd.
₹ 172.90
Medicamen Biotech Ltd.
₹ 463.15
Zenotech Laboratories Ltd.
₹ 95.87
Zim Laboratories Ltd.
₹ 112.95
Valiant Laboratories Ltd.
₹ 121.97
Accent Microcell Ltd.
₹ 275.90

Similar stocks

Similar Stocks

Lyka Labs Ltd.
₹ 152.90
Vikram Thermo (India) Ltd.
₹ 172.90
Medicamen Biotech Ltd.
₹ 463.15
Zenotech Laboratories Ltd.
₹ 95.87
Zim Laboratories Ltd.
₹ 112.95
Valiant Laboratories Ltd.
₹ 121.97
Accent Microcell Ltd.
₹ 275.90
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
545.7
97.9
172.5
Vikram Thermo (India) Ltd.
-
-
-
588.88
355.45
729.6
Zenotech Laboratories Ltd.
-
-
-
Zim Laboratories Ltd.
-
-
-
529.96
100.2
214.95
Accent Microcell Ltd.
-
-
-

News

Zim Laboratories Ltd Company background

Founded in: 1984
Managing director: Anwar S Daud
Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector.During the year 201920, ZIM Health Technologies Limited was acquired thereby resulting as a wholly owned subsidiary of the company . SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/Pharmerging Markets and EU.
Read More

Zim Laboratories Ltd FAQs

Zim Laboratories Ltd shares are currently priced at 112.64 on NSE and 112.95 on BSE as of 9/17/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Zim Laboratories Ltd [ZIMLAB] share was -7.17. The Zim Laboratories Ltd [ZIMLAB] share hit a 1-year low of Rs. 89.5 and a 1-year high of Rs. 131.4.

The market cap of Zim Laboratories Ltd is Rs. 548.85 Cr. as of 9/17/2024 12:00:00 AM.

The PE ratios of Zim Laboratories Ltd is 31.2 as of 9/17/2024 12:00:00 AM.

The PB ratios of Zim Laboratories Ltd is 2.37 as of 9/17/2024 12:00:00 AM

You can easily buy Zim Laboratories Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

Submit
personImage
Open Demat Account
+91 -

Submit
Download App
Open Account
Open Demat Account
+91 -

Submit
personImage